Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Fries

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Vaccine|April 1, 1996
Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector systemL F Fries, J Tartaglia, J Taylor, et al.
Infection and Immunity|June 13, 2001
Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adultsL F Fries, A D Montemarano, C P Mallett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1986
Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascadeL F Fries, H M Friedman, G H Cohen, et al.
Journal of Clinical Microbiology|March 1, 1992
Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteersM L Clements, E K Subbarao, L F Fries, et al.
Virology|December 1, 1988
Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralizationS Vasantha, K L Coelingh, B R Murphy, et al.
American Journal of Human Genetics|September 1, 1981
Inheritance of mixed cryoglobulinemiaS D Nightingale, R P Pelley, N L Delaney, et al.
Microbial Pathogenesis|December 1, 1987
Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2R J Eisenberg, M Ponce de Leon, H M Friedman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1992
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategyL F Fries, D M Gordon, R L Richards, et al.
Journal of Virology|November 1, 1988
C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2C Seidel-Dugan, M Ponce de Leon, H M Friedman, et al.
The Pediatric Infectious Disease Journal|January 1, 1995
Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of ageR A Karron, M C Steinhoff, E K Subbarao, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Vaccine|April 1, 1996
Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector systemL F Fries, J Tartaglia, J Taylor, et al.
Infection and Immunity|June 13, 2001
Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adultsL F Fries, A D Montemarano, C P Mallett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1986
Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascadeL F Fries, H M Friedman, G H Cohen, et al.
Journal of Clinical Microbiology|March 1, 1992
Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteersM L Clements, E K Subbarao, L F Fries, et al.
Virology|December 1, 1988
Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralizationS Vasantha, K L Coelingh, B R Murphy, et al.
American Journal of Human Genetics|September 1, 1981
Inheritance of mixed cryoglobulinemiaS D Nightingale, R P Pelley, N L Delaney, et al.
Microbial Pathogenesis|December 1, 1987
Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2R J Eisenberg, M Ponce de Leon, H M Friedman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1992
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategyL F Fries, D M Gordon, R L Richards, et al.
Journal of Virology|November 1, 1988
C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2C Seidel-Dugan, M Ponce de Leon, H M Friedman, et al.
The Pediatric Infectious Disease Journal|January 1, 1995
Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of ageR A Karron, M C Steinhoff, E K Subbarao, et al.
Pageof 5